Transactions
We have advised and participated in many of the most notable transactions and companies in cannabis.
Our Transactions
Acted as Financial Advisor to Acreage Holdings on the divestiture of its asset package in Maine.
*Pending regulatory approval.
Acted as Financial Advisor to Fine Fettle on the divestiture of its vertical asset package in Martha's Vineyard, Massachusetts.
*Pending regulatory approval.
Acted as Financial Advisor to Grön on the negotiation of it's secured credit facility with AFC Gamma.
Ran a competitive auction process, resulting in value maximization for Cresco Labs. Acted as Financial Advisor to Cresco Labs.
Acted as Financial Advisor to a national cannabis REIT in identifying a new lessee on a defaulted lease transaction, as well negotiating the sale of the related license.
SSC has served as a strategic Financial Advisor to Cresco Labs since 2020.
Acted as Financial Advisor, sourcing a strategic buyer and successfully negotiated a value maximizing transaction.
Advised the Board of Lyphe Group, a leading UK operator, on an independent valuation for a PE-led financing and internal restructuring.
SSC has served as Chief Restructuring Officer since January 2023, leading the turnaround and restructuring of balance sheet obligations and managing of various stakeholders.
Acted as Financial Advisor to VIVO on the strategic merger with MediPharm Labs.
Acted as Financial Advisor to Curaleaf on the sale to Greenlight.
SSC has acted as strategic Financial Advisor to Hoodie since June 2022, advising on strategy and capital market initiatives.
Navigated complexities to complete an industry first three-way California cannabis merger. Acted as Financial Advisor to Harborside.
SSC has acted as strategic Financial Advisor to Natures Grace & Wellness since summer 2021, advising on M&A and strategic initiatives.
Stoic was a principal investor in Apothecanna and helped lead a restructuring process prior to acting as Financial Advisor on the sale to HempFusion.
Co-founded Trichome in 2017 to offer credit-based capital solutions to companies operating in the legal cannabis market. Brian Schinderle still serves on the Board of IM Cannabis.
Acted as Financial Advisor in the Sale Investor Solicitation Process (SISP) under the supervision of the Special Committee of the Board of Directors of the Corporation and Monitor.
Acted as an expert witness for Aphria Inc. on a corporate litigation file.
Acted as Financial Advisor to WeedMD on the strategic merger with Starseed Holdings.
Acted as Financial Advisor to Village Bloomery on the strategic investment by Canopy Growth.
Acted as Financial Advisor to Grassroots through several capital market activities, including an eventual sale to Curaleaf (closed in July 2020).
Acted as Financial Advisor to Whistler Medical Marijuana Cannabis (WMMC), Canada’s first certified organic cultivator, on numerous corporate initiatives including a successful sale process and value maximizing exit.
.webp)
Advised a Tier 1 MSO on the valuation of several single state entities prior to its go-public event.
Ran a competitive auction process, resulting in value maximization for all Canna Farms stakeholders. Acted as Financial Advisor to Canna Farms.
Ran a competitive auction process, resulting in value maximization for all Canveda stakeholders. Acted as Financial Advisor to Canveda.
Provided independent valuation analysis to CannaRoyalty prior to the acquisition announcement.
Ran a competitive auction process, resulting in value maximization for all Bloomera stakeholders. Acted as Financial Advisor to Bloomera.
Acted as Financial Advisor to Aphria on the largest ever international cannabis M&A transaction.
Successfully navigated a competitive auction process on behalf of Aphria, completing a market moving transaction. Acted as Financial Advisor to Aphria.
Aaron Salz was Acting CFO of Tokyo Smoke from 2016 through early 2018, leading the company through all capital markets initiatives, including a public market exit.
Provided financial modeling and project analysis support to Alliance One for potential participation in the cannabis industry.
Produced a comprehensive project cost and output analysis report on indoor vs. greenhouse cultivation.
Ran a competitive auction process, resulting in value maximization for all RockGarden stakeholders. Acted as Financial Advisor to RockGarden.
Provided Romspen a comprehensive valuation and diligence report related to a potential secured loan to a California cultivator.
Advised WeedMD’s Board and management on many of its most important business decisions from 2016 through the ultimate merger with Starseed Holdings in 2019.